ArticlePharmaceutics2025

Population Pharmacokinetics of Tideglusib in Congenital and Childhood Myotonic Dystrophy Type 1: Influence of Demographic and Clinical Factors on Systemic Exposure.

Alessandro Di Deo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.